Here are five insights:
1. Around 772,790 people participated in the observational study.
2. The study subjects were asked to participate in guiac fecal occult blood testing screening over two years.
3. Of the 1,979 individuals who were diagnosed with CRC during the study period, 25 percent of the cases detected were within two years of a negative screening result.
4. The study suggests that guiac fecal occult blood testing should be replaced by more sensitive screening methods to improve detection rates.
5. The study suggests fecal immunochemical testing, which has been shown to help increase CRC detection.
More articles on GI/endoscopy:
GI physician leader to know: Dr. Shivagi Kothari of University of Rochester Medical Center
EndoChoice receives average price target of $19.67: 4 points
URMC GI experts to host advanced endoscopy course for nurses, mid-level providers: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.